-
- Remo Panaccione
- Inflammatory Bowel Disease Clinic, Assistant Professor of Medicine, University of Calgary, Rm. 6D32, TRW Building, 3280 Hospital Drive NW, Calgary, Alberta T2N 4N1,
-
- Subrata Ghosh
- Medicine, Inflammatory Bowel Disease Clinic, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada
説明
<jats:p> Crohn’s disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago has offered a new option for patients failing conventional therapy. Over time, biologic therapy has also led to the desire to achieve treatment goals beyond the control of symptoms. In order to achieve short-term and long-term goals with these new agents, it is important to review how these therapies may be optimized for the best results. </jats:p>
収録刊行物
-
- Therapeutic Advances in Gastroenterology
-
Therapeutic Advances in Gastroenterology 3 (3), 179-189, 2010-01-18
SAGE Publications
